Clinical trial
The Use of Inflammatory Markers to Guide Therapy in Children With Severe Asthma
NCT00262340 · Royal Brompton & Harefield NHS Foundation Trust, Other · Completed
Key facts
| NCT number | NCT00262340 |
|---|---|
| Title | The Use of Inflammatory Markers to Guide Therapy in Children With Severe Asthma |
| Official title | Prospective, Randomised Controlled Trial of the Use of Inflammatory Markers to Guide Therapy in Children With Severe Asthma |
| Lead sponsor | Royal Brompton & Harefield NHS Foundation Trust, Other |
| Collaborators | National Heart and Lung Institute Imperial College London British Lung Foundation |
| Status | Completed |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Other |
| Interventions | Non invasive measurement of airway inflammation |
| Enrollment | 55 |
| Start date | Dec 1, 2005 |
| Primary completion | Feb 1, 2008 |
| Completion | Feb 1, 2008 |
| First posted | Dec 6, 2005 |
| Last update posted | Oct 29, 2015 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: